» Articles » PMID: 10817756

The Steroid Receptor Coactivator, GRIP-1, is Necessary for MEF-2C-dependent Gene Expression and Skeletal Muscle Differentiation

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2000 May 19
PMID 10817756
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptor-mediated activation of transcription involves coactivation by cofactors collectively denoted the steroid receptor coactivators (SRCs). The process also involves the subsequent recruitment of p300/CBP and PCAF to a complex that synergistically regulates transcription and remodels the chromatin. PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment. Skeletal muscle differentiation and the activation of muscle-specific gene expression is dependent on the concerted action of another bHLH factor, myogenin, and the MADS protein, MEF-2, which function in a cooperative manner. We examined the functional role of one SRC, GRIP-1, in muscle differentiation, an ideal paradigm for the analysis of the determinative events that govern the cell's decision to divide or differentiate. We observed that the mRNA encoding GRIP-1 is expressed in proliferating myoblasts and post-mitotic differentiated myotubes, and that protein levels increase during differentiation. Exogenous/ectopic expression studies with GRIP-1 sense and antisense vectors in myogenic C2C12 cells demonstrated that this SRC is necessary for (1) induction/activation of myogenin, MEF-2, and the crucial cell cycle regulator, p21, and (2) contractile protein expression and myotube formation. Furthermore, we demonstrate that the SRC GRIP-1 coactivates MEF-2C-mediated transcription. GRIP-1 also coactivates the synergistic transactivation of E box-dependent transcription by myogenin and MEF-2C. GST-pulldowns, mammalian two-hybrid analysis, and immunoprecipitation demonstrate that the mechanism involves direct interactions between MEF-2C and GRIP-1 and is associated with the ability of the SRC to interact with the MADS domain of MEF-2C. The HLH region of myogenin mediates the direct interaction of myogenin and GRIP-1. Interestingly, interaction with myogenic factors is mediated by two regions of GRIP-1, an amino-terminal bHLH-PAS region and the carboxy-terminal region between amino acids 1158 and 1423 (which encodes an activation domain, has HAT activity, and interacts with the coactivator-associated arginine methyltransferase). This work demonstrates that GRIP-1 potentiates skeletal muscle differentiation by acting as a critical coactivator for MEF-2C-mediated transactivation and is the first study to ascribe a function to the amino-terminal bHLH-PAS region of SRCs.

Citing Articles

Per-ARNT-Sim (PAS) Domains in Basic Helix-Loop-Helix (bHLH)-PAS Transcription Factors and Coactivators: Structures and Mechanisms.

Daffern N, Radhakrishnan I J Mol Biol. 2023; 436(3):168370.

PMID: 37992889 PMC: 10922228. DOI: 10.1016/j.jmb.2023.168370.


A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.

Song Y, Yang M, Zhang S, Wang H, Kai K, Yao C Oncogene. 2022; 41(49):5223-5237.

PMID: 36309571 DOI: 10.1038/s41388-022-02521-5.


Clinical findings from the landmark MEF2C-related disorders natural history study.

Cooley Coleman J, Sarasua S, Moore H, Boccuto L, Cowan C, Skinner S Mol Genet Genomic Med. 2022; 10(6):e1919.

PMID: 35416405 PMC: 9184670. DOI: 10.1002/mgg3.1919.


ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.

Fishman H, Madiwale S, Geron I, Bari V, Van Loocke W, Kirschenbaum Y Blood. 2021; 139(3):399-412.

PMID: 34624096 PMC: 9906988. DOI: 10.1182/blood.2020010405.


Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling.

Bruno N, Nwachukwu J, Srinivasan S, Nettles C, Izard T, Jin Z Nat Chem Biol. 2021; 17(3):307-316.

PMID: 33510451 PMC: 8783757. DOI: 10.1038/s41589-020-00719-w.


References
1.
Sartorelli V, Huang J, Hamamori Y, Kedes L . Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 1997; 17(2):1010-26. PMC: 231826. DOI: 10.1128/MCB.17.2.1010. View

2.
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B . A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996; 85(3):403-14. DOI: 10.1016/s0092-8674(00)81118-6. View

3.
Molkentin J, Black B, Martin J, Olson E . Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol. 1996; 16(6):2627-36. PMC: 231253. DOI: 10.1128/MCB.16.6.2627. View

4.
Suen C, Berrodin T, Mastroeni R, Cheskis B, Lyttle C, Frail D . A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem. 1998; 273(42):27645-53. DOI: 10.1074/jbc.273.42.27645. View

5.
McKenna N, Lanz R, OMalley B . Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999; 20(3):321-44. DOI: 10.1210/edrv.20.3.0366. View